REGULATED PRESS RELEASE published on 03/22/2024 at 07:00, 2 years 3 months ago Biophytis a présenté son protocole de phase 3 dans le traitement de la sarcopénie Biophy's présente son protocole de phase 3 pour traiter la sarcopénie lors de l'ICFSR. L'étude SARA-31 évaluera l'efficacité de RuvembriTM. Biophytis recherche des partenaires pour le développement Biophytis RuvembriTM Sarcopénie Biophy's Protocole De Phase 3
REGULATED PRESS RELEASE published on 03/22/2024 at 07:00, 2 years 3 months ago Biophytis presented its phase 3 protocol in the treatment of sarcopenia Biophytis presents phase 3 protocol for sarcopenia treatment at ICFSR conference, showcasing the potential of RuvembriTM. CEO Stanislas Veillet seeks partners for drug development and financing Biophytis RuvembriTM Clinical-stage Biotechnology Phase 3 Protocol Sarcopenia Treatment
BRIEF published on 03/18/2024 at 07:05, 2 years 3 months ago Biophytis annonce sa prochaine Assemblée Générale Mixte pour le 02 avril 2024 Biophytis Assemblée Générale Mixte Société Biotechnologique Vote Des Actionnaires Médicaments Vieillissement
BRIEF published on 03/18/2024 at 07:05, 2 years 3 months ago Biophytis Announces Combined General Meeting for April 2024 Biophytis RuvembriTM Clinical-stage Biotechnology Combined General Meeting Age-related Diseases
REGULATED PRESS RELEASE published on 03/18/2024 at 07:00, 2 years 3 months ago Assemblée générale mixte du 02 avril 2024 Assemblée générale mixte de Biophytis SA prévue le 02 avril 2024 à Paris. Actionnaires invités à voter en amont. Informations sur le site internet de la Société Assemblée Générale Mixte Biophytis SA Vote Actionnaires Développement Médicaments Maladies Liées Au Vieillissement
REGULATED PRESS RELEASE published on 03/18/2024 at 07:00, 2 years 3 months ago Combined General Meeting of April 2, 2024 Biophytis SA will hold its Combined General Meeting (CGM) on April 2, 2024 at Sorbonne Université, Paris. Shareholders can vote in advance. The company specializes in developing therapies for age-related diseases Therapeutics Combined General Meeting Biophytis SA Age-related Diseases CGM
BRIEF published on 03/15/2024 at 23:05, 2 years 3 months ago Biophytis met en œuvre le regroupement de ses actions pour réduire la volatilité Marché Financier Biophytis Biotechnologie Regroupement D'actions Volatilité Du Titre
BRIEF published on 03/15/2024 at 23:05, 2 years 3 months ago Biophytis Announces Reverse Stock Split on Euronext Growth Biophytis Biotechnology Shareholder Value Reverse Stock Split Euronext Growth
REGULATED PRESS RELEASE published on 03/15/2024 at 23:00, 2 years 3 months ago Biophytis annonce le lancement du regroupement des actions composant son capital social Biophytis annonce le regroupement des actions de son capital social pour stabiliser l'action et favoriser son développement. Détails du regroupement et calendrier prévus Euronext Growth Paris Actionnaires Biophytis Regroupement Des Actions Stabilisation
REGULATED PRESS RELEASE published on 03/15/2024 at 23:00, 2 years 3 months ago Biophytis announces the implementation of a reverse stock split of its ordinary shares traded on Euronext Growth Biophytis implements a reverse stock split for its ordinary shares on Euronext Growth Paris and Nasdaq CM to stabilize share price. Details of the operation and key dates provided Biophytis Reverse Stock Split Euronext Growth Nasdaq CM Share Price Stabilization
Published on 06/23/2026 at 16:10, 1 hour 17 minutes ago Datavault AI Inc. (NASDAQ: DVLT) and WiSA Technologies Announce the Goho LS7 2.0 and 5.1 Home Theater Systems with WiSA E Wireless Connectivity
Published on 06/23/2026 at 16:00, 1 hour 27 minutes ago Secure Blockchain Appoints Former Polygon Executive Steven Bryson-Haynes as CEO to Drive Enterprise AI Commercialization
Published on 06/23/2026 at 15:45, 1 hour 42 minutes ago Amdocs Advances aOS Network Workflows with Live, Multivendor AI-RAN Solution and Industry Blueprint
Published on 06/23/2026 at 15:30, 1 hour 57 minutes ago Silver Spruce Resources, Inc. Adds Mine Production Knowledge to the Board
Published on 06/23/2026 at 15:30, 1 hour 57 minutes ago Galantas Gold Completes Transaction to Acquire Andacollo Gold
Published on 06/23/2026 at 16:58, 29 minutes ago Original-Research: HORNBACH Holding AG & Co. KGaA (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 06/23/2026 at 16:20, 1 hour 6 minutes ago STRATEC ANNUAL GENERAL MEETING RESOLVES DIVIDEND AND APPROVES ALL PROPOSED RESOLUTIONS
Published on 06/23/2026 at 16:15, 1 hour 12 minutes ago Roubini, Longtime Crypto Skeptic, Co-Authors Whitepaper and Backs Atlas's New Digital Reserve Asset
Published on 06/23/2026 at 16:47, 40 minutes ago Déclaration des transactions sur actions propres réalisées du 15/06/2026 au 19/06/2026
Published on 06/23/2026 at 16:47, 40 minutes ago Statement of transactions in own shares from June 15, 2026 to June 19, 2026
Published on 06/23/2026 at 15:44, 1 hour 43 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 15 au 19 juin 2026
Published on 06/23/2026 at 15:44, 1 hour 43 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from June 15 to June 19 2026
Published on 06/23/2026 at 14:00, 3 hours 27 minutes ago Neoen remporte un contrat long terme pour une nouvelle batterie de 200 MW / 8 heures en Ontario